Literature DB >> 11165056

Estrogen receptor alpha and estrogen receptor-related receptor alpha1 compete for binding and coactivator.

Z Zhang1, C T Teng.   

Abstract

The human estrogen receptor (ERalpha) and the human estrogen receptor-related receptor (ERRalpha1, NR3B1a) are members of the steroid/thyroid hormone receptor superfamily. We previously cloned an isoform of ERRalpha1 cDNA and demonstrated that ERRalpha1 binds to the human lactoferrin gene promoter and enhances estrogen responsiveness during transient transfection experiments. In this study, we show that ERRalpha1 and ERalpha may interfere in each other's transcriptional activity by competition for binding and coactivator. A VP16-ERRalpha1 chimera was constructed and transiently transfected into human endometrial carcinoma HEC-1B cells. This chimera activated reporter constructs containing the human lactoferrin gene estrogen response element (ERE) and the synthetic palindromic 3X-ERE, suggesting that ERRalpha1 binds to these EREs. Therefore, ERRalpha1 can compete with ERalpha for binding to the same EREs. ERRalpha1 is organized into modules which include a N-terminal region that shows repression function, a Zn-finger region that binds DNA and an activation region at the C terminus. The activation function of ERRalpha1 was mapped to the conserved AF2 region in the C-terminus by deletion analysis. The transactivation activity of ERRalpha1 can be enhanced by coactivator (SRC-1a) and suppressed by ERalpha in the presence of estrogen, suggesting that SRC-1a is required by both receptors for their activity. The repression of ERRalpha1 activation function by estrogen bound ERalpha, however, could not be reversed by increasing concentration of SRC-1a in the cells. This finding is consistent with the squelching phenomenon that exists between ERalpha and other steroid receptor family members. The studies demonstrated that ERRalpha1 and ERalpha may potentially regulate the same target gene independently as well as interfere with each other's functional activity by competition for binding and coactivator.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11165056     DOI: 10.1016/s0303-7207(00)00372-5

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  16 in total

1.  Estrogen-related receptor ERRα-mediated downregulation of human hydroxysteroid sulfotransferase (SULT2A1) in Hep G2 cells.

Authors:  Chaoqun Huang; Tianyan Zhou; Yue Chen; Teng Sun; Shufen Zhang; Guangping Chen
Journal:  Chem Biol Interact       Date:  2011-04-13       Impact factor: 5.192

2.  Optimal constrained stationary intervention in gene regulatory networks.

Authors:  Babak Faryabi; Golnaz Vahedi; Jean-Francois Chamberland; Aniruddha Datta; Edward R Dougherty
Journal:  EURASIP J Bioinform Syst Biol       Date:  2008

3.  Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells.

Authors:  Pengming Sun; Jalid Sehouli; Carsten Denkert; Alexander Mustea; Dominique Könsgen; Ines Koch; Lihui Wei; Werner Lichtenegger
Journal:  J Mol Med (Berl)       Date:  2005-03-16       Impact factor: 4.599

4.  Interplay between estrogen-related receptor alpha (ERRalpha) and gamma (ERRgamma) on the regulation of ERRalpha gene expression.

Authors:  Zhiping Zhang; Christina T Teng
Journal:  Mol Cell Endocrinol       Date:  2006-12-08       Impact factor: 4.102

5.  Recent advances in intervention in markovian regulatory networks.

Authors:  Babak Faryabi; Golnaz Vahedi; Aniruddha Datta; Jean-Francois Chamberland; Edward R Dougherty
Journal:  Curr Genomics       Date:  2009-11       Impact factor: 2.236

6.  Estrogen-related receptor alpha is critical for the growth of estrogen receptor-negative breast cancer.

Authors:  Rebecca A Stein; Ching-Yi Chang; Dmitri A Kazmin; James Way; Thies Schroeder; Melanie Wergin; Mark W Dewhirst; Donald P McDonnell
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

7.  Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha.

Authors:  Jiangming Luo; Robert Sladek; Julie Carrier; Jo-Ann Bader; Denis Richard; Vincent Giguère
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

8.  A model for aryl hydrocarbon receptor-activated gene expression shows potency and efficacy changes and predicts squelching due to competition for transcription co-activators.

Authors:  Ted W Simon; Robert A Budinsky; J Craig Rowlands
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

Review 9.  Novel drugs that target the estrogen-related receptor alpha: their therapeutic potential in breast cancer.

Authors:  Felicity Eb May
Journal:  Cancer Manag Res       Date:  2014-05-23       Impact factor: 3.989

10.  Anti-diabetic rosiglitazone remodels the adipocyte transcriptome by redistributing transcription to PPARγ-driven enhancers.

Authors:  Sonia E Step; Hee-Woong Lim; Jill M Marinis; Andreas Prokesch; David J Steger; Seo-Hee You; Kyoung-Jae Won; Mitchell A Lazar
Journal:  Genes Dev       Date:  2014-05-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.